Frequently Asked Questions
Why talk about endocrine disruptors today?
Because their effects on human health are now widely documented by scientific research and acknowledged by public health agencies, while population-wide exposure continues on a large scale.
Aren’t the doses too low to be dangerous?
No. Endocrine disruptors can have effects at very low doses. Their danger also lies in repeated and cumulative exposure, as well as in the “cocktail effect” resulting from simultaneous exposure to multiple substances.
Why focus on cosmetics and perfumes?
Because they are applied directly to the skin, sometimes several times a day, and used over long periods of time. Perfumes also involve a particularly high level of compositional opacity.
If these substances are authorized, are they really dangerous?
Regulatory authorization does not mean the absence of risk. Regulations evolve slowly and often reflect compromises. Many substances were authorized before their effects were fully understood.
Do alternatives exist?
Yes. Technical alternatives exist and are already used by some market players. The continued use of hazardous substances is the result of an industrial and economic choice.
What does the collective do in practice?
We inform, document, formally engage with brands, conduct targeted public campaigns, and support affected individuals when accountability needs to be pursued.
Is this an ideological fight?
No. Our approach is grounded in scientific evidence, publicly available data, and a commitment to public health accountability.